Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
24
Bearish filings
9
Named actors
14
Disclosed $ (bull / bear)
$5.5M / $2.6M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-07-08 | 5%+ holder (13G) FMR LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-06-30 | Officer (via E-TRADE FINANCIAL CORPORATION) AOIFE BRENNAN | filed notice to sell | $407K | SEC ↗ |
| 2026-06-29 | President and CEO Brennan Aoife | sold | $407K | SEC ↗ |
| 2026-06-12 | Issuer (share issuance) | priced an offering | — | SEC ↗ |
| 2026-02-26 | Director Thomas Stephen Basil | sold | $114K | SEC ↗ |
8 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-02-25 | Director Thomas Stephen Basil | sold | $236K | SEC ↗ |
| 2026-02-25 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) STEPHEN THOMAS | filed notice to sell | $318K | SEC ↗ |
| 2026-02-17 | 5%+ holder (13G) MPM BioImpact LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-02-13 | Director Thomas Stephen Basil | sold | $58K | SEC ↗ |
| 2026-02-12 | Director Thomas Stephen Basil | sold | $471K | SEC ↗ |
| 2026-02-12 | Director (via Morgan Stanley Smith Barney LLC Executive Financial Services) STEPHEN THOMAS | filed notice to sell | $556K | SEC ↗ |
| 2026-01-05 | Director RA CAPITAL MANAGEMENT, L.P. | bought | $25K | SEC ↗ |
| 2026-01-05 | Director RA Capital Nexus Fund III, L.P. | bought | $25K | SEC ↗ |
| 2026-01-05 | Director RA Capital Healthcare Fund LP | bought | $25K | SEC ↗ |
| 2026-01-05 | Director Kolchinsky Peter | bought | $25K | SEC ↗ |
| 2026-01-05 | Director RA Capital Nexus Fund II, L.P. | bought | $25K | SEC ↗ |
| 2026-01-05 | Director RA Capital Nexus Fund, L.P. | bought | $25K | SEC ↗ |
| 2026-01-05 | Director Shah Rajeev M. | bought | $25K | SEC ↗ |
| 2025-12-12 | Director Shah Rajeev M. | bought | $290K | SEC ↗ |
| 2025-12-12 | Director RA Capital Nexus Fund III, L.P. | bought | $290K | SEC ↗ |
| 2025-12-12 | Director RA CAPITAL MANAGEMENT, L.P. | bought | $290K | SEC ↗ |
| 2025-12-12 | Director RA Capital Nexus Fund, L.P. | bought | $290K | SEC ↗ |
| 2025-12-12 | Director RA Capital Healthcare Fund LP | bought | $290K | SEC ↗ |
| 2025-12-12 | Director RA Capital Nexus Fund II, L.P. | bought | $290K | SEC ↗ |
| 2025-12-12 | Director Kolchinsky Peter | bought | $290K | SEC ↗ |